Cite
MLA Citation
D. Isenberg et al.. “OP0184 Efficacy and Safety of Tabalumab in Patients with Systemic Lupus Erythematosus (SLE): Results from 2 Phase 3, 52-Week, Multicenter, Randomized, Placebo-Controlled Trials.” Annals of the rheumatic diseases, vol. 74, n.d., p. 141. http://access.bl.uk/ark:/81055/vdc_100135156627.0x000059